Both MISP mRNA and protein levels were dramatically increased in lung cancer tissues (Figure 1D–F; Figure S1B, Supporting Information), and elevated MISP predicted worse clinical outcomes in patients with lung cancer (Figure 1G). This evidence concerns the gene MISP and lung carcinoma.